Jana D Brightman, LVN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 672 Vz County Road 1922, Fruitvale, TX 75127 Phone: 903-292-8277 |
News Archive
In four separate pivotal clinical studies presented on Friday, a greater percentage of moderate to severe chronic plaque psoriasis patients treated with briakinumab, Abbott's investigational IL-12/23 inhibitor (ABT-874), achieved 75 percent or better skin clearance rates than those treated with etanercept (EnbrelĀ®), methotrexate or placebo. Abbott presented data from all briakinumab pivotal studies in psoriasis at the European Association of Dermatology and Venereology scientific sessions.
Psychiatric Solutions, Inc. today announced financial results for the first quarter ended March 31, 2010. Revenue increased 9.7% for the first quarter to $476.0 million from $433.9 million for the first quarter of 2009. Income from continuing operations attributable to PSI stockholders increased 15.2% to $31.7 million from $27.5 million. Income from continuing operations attributable to PSI stockholders per diluted share was $0.56 for the first quarter of 2010, up 14.3% from $0.49 for the first quarter of 2009.
Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer, according to a study* released today by scientists from the National Cancer Institute (NCI).
New research is showing a beneficial side effect of parasites for our health. Hygiene Hypothesis: As rates of allergy are reported to have tripled in the UK in the past decade, the scientific finger is pointing to an over-sanitised lifestyle making our immune responses overactive. Now, a team of biologists at the University of Edinburgh, led by Professor Rick Maizels, are investigating how parasitic worms could offer a cure for modern illnesses.
› Verified 1 days ago